Lowest Price Guaranteed
Pages
233
Last Updated
September 2026
View Count
5495
1. PREFACE
1.1. Introduction
1.2. Market Key Insights
1.3. Market Segmentation
1.4. Market Share Insights
1.5. Key Questions Answered
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
5.1. Chapter Overview
5.2. Executive Summary: Artificial Organs and Bionics Market Landscape
5.3. Executive Summary: Artificial Organs and Bionics Market Trends
5.4. Executive Summary: Market Forecast and Opportunity Analysis
6. INTRODUCTION
6.1. Chapter Overview
6.2. Introduction to Artificial Organs and Bionics
6.3. Classification of Artificial Organs and Bionic Systems
6.4. Clinical and Functional Role of Artificial Organs and Bionics
6.5. Key Stakeholders in the Artificial Organs and Bionics Market
6.6. Benefits and Limitations of Artificial Organs and Bionic Systems
6.7. Future Perspectives
7. REGULATORY LANDSCAPE
8. MARKET ACCESS AND REIMBURSEMENT
9. ARTIFICIAL ORGANS AND BIONICS MARKET LANDSCAPE
9.1. Chapter Overview
9.2. Artificial Organs and Bionics Market: Overall Landscape
9.3. Analysis by Year of Establishment
9.4. Analysis by Company Size
9.5. Analysis by Headquarters
9.6. Analysis by Type of Product
9.7. Analysis by Technology
9.8. Analysis by System Placement
9.9. Analysis by End User
9.10. Analysis by Geographic Coverage
10. COMPANY COMPETITIVENESS ANALYSIS
10.1. Chapter Overview
10.2. Key Parameters
10.3. Methodology
10.4. Company Competitiveness Analysis
10.4.1. Artificial Organs and Bionics Product Manufacturing Companies Headquartered in North America
10.4.2. Artificial Organs and Bionics Product Manufacturing Companies Headquartered in Europe
10.4.3. Artificial Organs and Bionics Product Manufacturing Companies Headquartered in Asia-Pacific and Rest of the World
11. COMPANY PROFILES
11.1. Chapter Overview
11.2. Abbott
11.2.1. Company Overview
11.2.2. Financial Information
11.2.3. Artificial Organs and Bionics Product / Technology Portfolio
11.2.4. Recent Developments and Future Outlook
11.3. Boston Scientific
11.3.1. Company Overview
11.3.2. Financial Information
11.3.3. Artificial Organs and Bionics Product / Technology Portfolio
11.3.4. Recent Developments and Future Outlook
11.4. Cochlear
11.4.1. Company Overview
11.4.2. Financial Information
11.4.3. Artificial Organs and Bionics Product / Technology Portfolio
11.4.4. Recent Developments and Future Outlook
11.5. Ekso Bionics
11.5.1. Company Overview
11.5.2. Financial Information
11.5.3. Artificial Organs and Bionics Product / Technology Portfolio
11.5.4. Recent Developments and Future Outlook
11.6. Embla Medical
11.6.1. Company Overview
11.6.2. Financial Information
11.6.3. Artificial Organs and Bionics Product / Technology Portfolio
11.6.4. Recent Developments and Future Outlook
11.7. Fresenius Medical Care
11.7.1. Company Overview
11.7.2. Financial Information
11.7.3. Artificial Organs and Bionics Product / Technology Portfolio
11.7.4. Recent Developments and Future Outlook
11.8. Insulet
11.8.1. Company Overview
11.8.2. Financial Information
11.8.3. Artificial Organs and Bionics Product / Technology Portfolio
11.8.4. Recent Developments and Future Outlook
11.9. Johnson & Johnson MedTech
11.9.1. Company Overview
11.9.2. Financial Information
11.9.3. Artificial Organs and Bionics Product / Technology Portfolio
11.9.4. Recent Developments and Future Outlook
11.10. LivaNova
11.10.1. Company Overview
11.10.2. Financial Information
11.10.3. Artificial Organs and Bionics Product / Technology Portfolio
11.10.4. Recent Developments and Future Outlook
11.11. Medtronic
11.11.1. Company Overview
11.11.2. Financial Information
11.11.3. Artificial Organs and Bionics Product / Technology Portfolio
11.11.4. Recent Developments and Future Outlook
11.12. Ottobock
11.12.1. Company Overview
11.12.2. Financial Information
11.12.3. Artificial Organs and Bionics Product / Technology Portfolio
11.12.4. Recent Developments and Future Outlook
11.13. Science Corporation
11.13.1. Company Overview
11.13.2. Artificial Organs and Bionics Product / Technology Portfolio
11.13.3. Recent Developments and Future Outlook
12. PARTNERSHIPS AND COLLABORATIONS
12.1. Chapter Overview
12.2. Partnership Models
12.3. Artificial Organs and Bionics Market: Partnerships and Collaborations
12.3.1. Analysis by Year of Partnership
12.3.2. Analysis by Type of Partnership
12.3.3. Analysis by Year and Type of Partnership
12.3.4. Analysis by Type of Partner
12.3.5. Most Active Players: Analysis by Number of Partnerships
12.3.6. Analysis by Geography
12.3.6.1. Analysis by Country
12.3.6.2. Analysis by Continent
13. FUNDING AND INVESTMENT ANALYSIS
13.1. Chapter Overview
13.2. Funding Models
13.3. Artificial Organs and Bionics Market: Funding and Investment Analysis
13.3.1. Analysis by Year of Funding
13.3.1.1. Cumulative Year-wise Trend of Funding Instances
13.3.1.2. Cumulative Year-wise Trend of Amount Invested
13.3.2. Analysis by Type of Funding
13.3.2.1. Analysis of Funding Instances
13.3.2.2. Analysis of Amount Invested
13.3.3. Analysis of Amount Invested by Year and Type of Funding
13.3.4. Analysis by Geography
13.3.5. Most Active Players
13.3.5.1. Analysis by Number of Funding Instances
13.3.5.2. Analysis by Amount Raised
14. MARKET IMPACT ANALYSIS
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Challenges
14.5. Market Opportunities
14.6. Conclusion
15. GLOBAL ARTIFICIAL ORGANS AND BIONICS MARKET
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Global Artificial Organs and Bionics Market: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
16. ARTIFICIAL ORGANS AND BIONICS MARKET, BY TYPE OF PRODUCT
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Artificial Organs and Bionics Market: Distribution by Type of Product
16.4. Artificial Organs and Bionics Market for Artificial Organs: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.4.1. Artificial Organs and Bionics Market for Artificial Heart: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.4.2. Artificial Organs and Bionics Market for Artificial Kidney: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.4.3. Artificial Organs and Bionics Market for Artificial Lung: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.4.4. Artificial Organs and Bionics Market for Artificial Liver: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.4.5. Artificial Organs and Bionics Market for Artificial Pancreas: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.4.6. Artificial Organs and Bionics Market for Other Artificial Organs: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.5. Artificial Organs and Bionics Market for Bionics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.5.1. Artificial Organs and Bionics Market for Hearing / Ear Bionics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.5.2. Artificial Organs and Bionics Market for Orthopedic Bionics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.5.2.1. Artificial Organs and Bionics Market for Bionic Limbs: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.5.2.2. Artificial Organs and Bionics Market for Medical Exoskeletons: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.5.3. Artificial Organs and Bionics Market for Vision Bionics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.5.4. Artificial Organs and Bionics Market for Neural / Brain Bionics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.5.5. Artificial Organs and Bionics Market for Other Bionics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.6. Data Triangulation and Validation
17. ARTIFICIAL ORGANS AND BIONICS MARKET, BY TECHNOLOGY
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Artificial Organs and Bionics Market: Distribution by Technology
17.4. Artificial Organs and Bionics Market for Mechanical / Electromechanical Systems: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.5. Artificial Organs and Bionics Market for Electronic / Bioelectronic Systems: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.6. Artificial Organs and Bionics Market for Bioartificial / Biohybrid Systems: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.7. Data Triangulation and Validation
18. ARTIFICIAL ORGANS AND BIONICS MARKET, BY SYSTEM PLACEMENT
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Artificial Organs and Bionics Market: Distribution by System Placement
18.4. Artificial Organs and Bionics Market for Implantable Systems: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
18.5. Artificial Organs and Bionics Market for Wearable / Body-worn Systems: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
18.6. Artificial Organs and Bionics Market for Extracorporeal / External Systems: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
18.7. Data Triangulation and Validation
19. ARTIFICIAL ORGANS AND BIONICS MARKET, BY END USER
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Artificial Organs and Bionics Market: Distribution by End User
19.4. Artificial Organs and Bionics Market for Hospitals & Surgical Centers: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.5. Artificial Organs and Bionics Market for Specialty Clinics & Rehabilitation Centers: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.6. Artificial Organs and Bionics Market for Home Care & Ambulatory Settings: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.7. Artificial Organs and Bionics Market for Other Institutional End Users: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.8. Data Triangulation and Validation
20. ARTIFICIAL ORGANS AND BIONICS MARKET, BY GEOGRAPHICAL REGIONS
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Artificial Organs and Bionics Market: Distribution by Geography
20.4. Artificial Organs and Bionics Market in North America: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.4.1. Artificial Organs and Bionics Market in US: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.4.2. Artificial Organs and Bionics Market in Canada: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.4.3. Artificial Organs and Bionics Market in Mexico: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.4.4. Artificial Organs and Bionics Market in Rest of North America: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.5. Artificial Organs and Bionics Market in Europe: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.5.1. Artificial Organs and Bionics Market in Germany: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.5.2. Artificial Organs and Bionics Market in UK: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.5.3. Artificial Organs and Bionics Market in Italy: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.5.4. Artificial Organs and Bionics Market in Spain: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.5.5. Artificial Organs and Bionics Market in France: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.5.6. Artificial Organs and Bionics Market in Netherlands: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.5.7. Artificial Organs and Bionics Market in Rest of Europe: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.6. Artificial Organs and Bionics Market in Asia-Pacific: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.6.1. Artificial Organs and Bionics Market in China: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.6.2. Artificial Organs and Bionics Market in India: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.6.3. Artificial Organs and Bionics Market in Japan: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.6.4. Artificial Organs and Bionics Market in South Korea: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.6.5. Artificial Organs and Bionics Market in Singapore: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.6.6. Artificial Organs and Bionics Market in Rest of Asia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.7. Artificial Organs and Bionics Market in Latin America: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.7.1. Artificial Organs and Bionics Market in Brazil: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.7.2. Artificial Organs and Bionics Market in Argentina: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.7.3. Artificial Organs and Bionics Market in Rest of Latin America: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.8. Artificial Organs and Bionics Market in Middle East and Africa: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.8.1. Artificial Organs and Bionics Market in Saudi Arabia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.8.2. Artificial Organs and Bionics Market in UAE: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.8.3. Artificial Organs and Bionics Market in Iran: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.8.4. Artificial Organs and Bionics Market in Egypt: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.8.5. Artificial Organs and Bionics Market in Rest of Middle East and Africa: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.9. Penetration Growth (P-G) Matrix
20.10. Data Triangulation and Validation
21. CONCLUDING INSIGHTS
22. INSIGHTS FROM PRIMARY RESEARCH
22.1. Chapter Overview
22.2. Company A
22.2.1. Company Snapshot
22.2.2. Interview Transcript: Founder and Owner, Small Company, Germany
22.3. Company B
22.3.1. Company Snapshot
22.3.2. Interview Transcript: Chief Executive Officer and Managing Director, Large Company, India
22.4. Company C
22.4.1. Company Snapshot
22.4.2. Interview Transcript: Chief Executive Officer and Chief Bioengineering Officer, Mid-sized Company, US
22.5. Company D
22.5.1. Company Snapshot
22.5.2. Interview Transcript: Co-founder, Small Company, US
22.6. Company E
22.6.1. Company Snapshot
22.6.2. Interview Transcript: Chief Technology Officer, Co-Founder, Small Company, India
22.7. Company F
22.7.1. Company Snapshot
22.7.2. Interview Transcript: Chief Scientific Officer (Biomaterials), Large Company, UK
22.8. Company G
22.8.1. Company Snapshot
22.8.2. Interview Transcript: Chief Medical Officer, Small Company, China
22.9. Company H
22.9.1. Company Snapshot
22.9.2. Interview Transcript: Senior Vice President and Global Head of Market Access, Large Company, Switzerland
22.10. Company I
22.10.1. Company Snapshot
22.10.2. Interview Transcript: Senior Vice President of Clinical Marketing, Small Company, US
22.11. Company J
22.11.1. Company Snapshot
22.11.2. Interview Transcript: Senior Director of Regulatory Affairs & Quality Assurance (RA/QA), Mid-sized Company, US
23. APPENDIX I: TABULATED DATA
24. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS